+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Presynaptic and postsynaptic neuromuscular effects of a specific inhibitor of acetylcholinesterase

Journal of Pharmacology and Experimental Therapeutics 215(1): 53-59

Presynaptic and postsynaptic neuromuscular effects of a specific inhibitor of acetylcholinesterase

Previous studies have shown indirectly that the neuromuscular effects of nonselective cholinesterase inhibitors are mediated through the inhibition of acetylcholinesterase (AChE). To test this hypothesis more directly we studied the effects of the specific inhibitor of AChE, BW 284c51, at the neuromuscular junction of rat diaphragms. BW 284c51 inhibits AChE in a dose-dependent partially reversible manner at all concentrations tested (10(-9) to 10(-4) M). Maximum inhibition was never greater than 92%. The drug increased miniature end-plate potential (MEPP) amplitude and prolonged half-decay time at 10(-7) and 10(-6) M. However, BE 284c51 had no effect on the resting membrane potential at any concentration. BW 284c51 at 10(-7) M reversibly increased MEPP frequency by almost 4-fold. There was a 2-fold increase in the occurrence of giant MEPPs in the presence of BW 284c51. The quantum content (m) of the end-plate potential was increased in 10(-7) M BW 284c51 as were end-plate potential amplitude and quantum size (q). Animals injected subcutaneously with 10 mg/kg of BW 284c51 displayed typical signs of AChE inhibition including salivation, whole body tremor and prostration. Spontaneous muscle fasciculation was more noticeable after in vivo injection of BW 284c51 than after in vitro administration. Furthermore, MEPP frequencies were considerably faster when the drug was injected in vivo than when applied in vitro. The data are discussed with respect to the hypothesis that inhibition of AChE causes presynaptic as well as postsynaptic effects.

Accession: 044022444

PMID: 6256519

Related references

Postsynaptic and presynaptic mechanisms of tubocurarine induced recovery of neuromuscular transmission after exposure to organophosphorus acetylcholinesterase inhibitor. Doklady Akademii Nauk SSSR 306(2): 499-502, 1989

Presynaptic or postsynaptic origin of acetylcholinesterase at neuromuscular junctions? An immunological study in heterologous nerve-muscle cultures. Developmental Biology 116(1): 69-77, 1986

Presynaptic and postsynaptic effects of corticosterone at the neuromuscular junction. Pfluegers Archiv European Journal of Physiology 413(SUPPL 1): R24, 1989

Presynaptic and postsynaptic effects of chromium iii at the frog neuromuscular junction. Society for Neuroscience Abstracts 10(1): 420, 1984

Presynaptic And Postsynaptic Effects Of Inhibitory Drugs On The Crayfish Neuromuscular Junction. Pflugers Archiv für die Gesamte Physiologie des Menschen und der Tiere 283: 104-118, 1965

Postsynaptic and presynaptic effects of vesamicol ah 5183 on the frog neuromuscular junction. European Journal of Pharmacology 147(2): 209-216, 1988

Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction. British Journal of Pharmacology 69(1): 119-121, 1980

Presynaptic and postsynaptic effects of the venom of the Australian tiger snake at the neuromuscular junction. British Journal of Pharmacology 49(2): 340-354, 1973

Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission. Muscle & Nerve 6(6): 442-447, 1983

Effects of acetylcholinesterase inhibitor therapy for Alzheimer's disease on neuromuscular block. British Journal of Anaesthesia 100(3): 420-420, 2008